BioVex raised €32M in a Series D+ round in Mar 2009. The company is based in Oxton, UK. Investors in the round: Innoven Partners, New Science Ventures, Omnes Venture Capital and 1 other. Data as of 6 Aug 2026.
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
